Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies

Published:2018-09-24 Issue:2 Volume:104 Page:550-556
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Piranavan Paramarajan¹^ORCID,Li Yan¹,Brown Edward²,Kemp E Helen³,Trivedi Nitin⁴

Affiliation:

1. Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts

2. Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

3. Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

4. Division of Endocrinology, Saint Vincent Hospital, Worcester, Massachusetts

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/2/550/27378256/jc.2018-01151.pdf

Reference19 articles.

1. Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy;Kumar;Front Pharmacol,2017

2. Immune-related adverse events associated with immune checkpoint blockade;Postow;N Engl J Med,2018

3. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management;Sznol;Cancer Treat Rev,2017

4. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review;Abdel-Wahab;Ann Intern Med,2018

5. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis;Barroso-Sousa;JAMA Oncol,2018

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine toxicity of cancer immunotherapy;International Journal of Molecular and Immuno Oncology;2024-08-31

2. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use;Endocrine Practice;2024-06

3. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group;Cancer Treatment Reviews;2024-05

4. Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort;The Journal of Clinical Endocrinology & Metabolism;2024-04-12

5. Research Advances of Immune Checkpoint Inhibitors Related Endocrine Adverse Events;Advances in Clinical Medicine;2024